Long Yibin
Assistant General Manager @ ZGC Group
Long Yibin is a Series B investor at ZGC Group focused on Therapeutics and Biotechnology. Long Yibin - Assistant General Manager @ ZGC Group
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Long Yibin invests in
Stages Long Yibin invests in
Countries Long Yibin invests in
Investment Focus
Industry
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
- Clinical Trials 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cygnus Biosciences
|
Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis. | $19.6M / Series B / Nov 14, 2017 |
Co-Investors
About ZGC Group
ZGC Group was established in 2010. With a consistent mission of serving innovation-driven development, it has been committed to building an open and shared ecosystem pooling innovation factors. To promote the transformation and industrialization of sci-tech achievements, it deploys innovative resources across the world by means of buildinghigh-tech parks, making investments, providing funding and professional services and etc. It now has become an integral part of Zhongguancun innovation and entrepreneurship ecosystem.
ZGC Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jun Yu
President
|
|||
|
Long Yibin
Assistant General Manager
|
|||
|
Ma Jianping
Managing Partner
|
|||
Zhao Changshan
Party Secretary and Chairman
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Long Yibin invest in?
Long Yibin invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Long Yibin last invest?
The most recent investment recorded for Long Yibin closed in Nov 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
